Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Clinical Study With Adalimumab Biosimilar
Phase 1
Completed
- Conditions
- PharmacokineticsSafety Issues
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Laboratorios Richmond S.A.C.I.F.
- Target Recruit Count
- 150
- Registration Number
- NCT06291948
- Locations
- 🇦🇷
FP Clinical Pharma S.R.L., Buenos Aires, Argentina
A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab
Phase 1
Completed
- Conditions
- PharmacokineticsSafety Issues
- First Posted Date
- 2019-04-18
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Laboratorios Richmond S.A.C.I.F.
- Target Recruit Count
- 112
- Registration Number
- NCT03919448
- Locations
- 🇦🇷
FP Clinical Pharma S.R.L., Buenos Aires, Argentina
News
No news found